Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

Abstract | Dec 9, 2023

Author

Issa GC, et al.

Congress

American Society of Hematology Annual Meeting 2023

San Diego, CA | Dec 9 – 12, 2023